期刊文献+

卵巢恶性上皮性肿瘤中树突状细胞的免疫组织化学研究 被引量:1

Immunohistochemical study on dendritic cells in epithelial ovarian cancer
下载PDF
导出
摘要 目的 探讨树突细胞在卵巢恶性上皮性肿瘤中的浸润情况及其临床意义。方法 用S -10 0蛋白抗体对48例卵巢恶性上皮性肿瘤组织中间质树突细胞进行免疫组化S -P法标记染色 ,并与正常组织及卵巢良性上皮性肿瘤对照。结果 卵巢恶性上皮性肿瘤组织中树突细胞浸润明显增多 (P <0 .0 1) ,树突细胞浸润数量与组织类型 ,分化程度无关 ,而与淋巴细胞浸润呈直线相关 (P <0 .0 1)。树突细胞浸润程度与患者预后呈正相关 (P <0 .0 5 )。结论 树突细胞的浸润可能与肿瘤免疫有关 ,肿瘤组织原位树突细胞计数 。 Objective To study the infiltration of dendritic cells(DC) in epithelial ovarian cancer. Methods \ Quantitative assessment of interstitial dendritic cells was performed by S-P immunohistochemical method in specimens of maligmant epithelial ovarian tumor ( n =48),benign epithelial ovarian tumor( n =30),and normal ovarian tissue( n =30). Results\ The number of DC in maligmant epithelial ovarian tumor increased significantly as compared with benign epithelial tumor and normal ovarian tissue( P <0.01).The DC number in maligmant epithelial ovarian tumor was not correlated with histologic types and differentiation grades, but was correlated with lymphocyte infiltration and survival rate. Conclusion\ DC may play a role in the host immune reaction against tumor and the number of DC in situ can serve as a useful indicator in assessing prognosis.
出处 《广东医学》 CAS CSCD 2001年第2期129-130,共2页 Guangdong Medical Journal
关键词 树突状细胞 S-100蛋白 免疫组织化学 卵巢恶性上皮性肿瘤 Dendritic cell Immunohistochemistry Ovarian cancer Prognosis
  • 相关文献

参考文献4

二级参考文献3

共引文献37

同被引文献14

  • 1叶枫,陈怀增,谢幸,叶大风.卵巢癌细胞株冻融抗原负载的树突状细胞诱导CTL抗卵巢癌免疫应答的体外研究[J].中华微生物学和免疫学杂志,2004,24(12):964-967. 被引量:9
  • 2[1]Levin D,Constant S,Pasqualini T,et al.Role of Dendritic Cells in the Priming of CD4+T Lymphocytes to Peptideantigen in Vivo[J].J Immunol,1993,151:6742.
  • 3[2]Schoenberger SP,Toes RE,Voort EI,et al.T Cell Help for Cytotoxic T Lymphocytes is Mediated by CD40 Linteractions[J].Nature,1998,393(6684):480~483.
  • 4[3]Heufler C,Koch F,Stanz lU,et al.Interleukin 12 is Produced by Dendritic Cell Sand Mediates the Lper1 Development as Well as Interferon Gammaproduction by T Helper Cells[J].Eur J Immunol,1996,26(3):659~668.
  • 5[5]Norbury CC.Dendritic Cells Pulsed with RNA are Potent Antigen-presenting Cells in Vitro and in Vivo[J].Eur J Immunol,1997,27(1):280~288.
  • 6[6]Zhou LJ,Tedder TF.A Distinct Pattern of Kine Gene Expression by Human CD+83 Blood Dendritic Cells[J].Blood,1995,86(9):3295~3301.
  • 7[7]Fong L,Engleman EG.Dendric Cells in Cancer Immuno Therapy[J].Annu Rev Immunol,2000,18:245~273.
  • 8[12]Brossart P,Wirths S,Stuhler G,et al.Induction of Cytotoxic T-lympho Cyte Responses in Vivo after Vaccination with Peptide Pulsed Dendritic Cells[J].Blood,2000,96(9):3102~3108.
  • 9[14]Ferrara AJ.Dendric Cells in Cancer Immunotherapy[J].Res Clin on Col,2003,129:521~530.
  • 10冯瑞娥,李敬军,王军梅,赵同建.乳腺癌组织中S-100蛋白阳性树突状细胞的研究[J].首都医科大学学报,1997,18(4):324-326. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部